Phase III trial completed by Bharat Biotech for Nasal Vaccine
The clinical phase III trials of the Covid-19 nasal vaccination have been finished, according to Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech, who stated the company will submit its data to the Drugs Controller General of India (DCGI) next month. Ella remarked, “We recently concluded a clinical experiment and are currently analysing…
